16-3606644-A-G
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_032444.4(SLX4):āc.590T>Cā(p.Val197Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00193 in 1,614,206 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V197M) has been classified as Uncertain significance.
Frequency
Consequence
NM_032444.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLX4 | NM_032444.4 | c.590T>C | p.Val197Ala | missense_variant | 3/15 | ENST00000294008.4 | |
SLX4 | XM_024450471.2 | c.590T>C | p.Val197Ala | missense_variant | 3/15 | ||
SLX4 | XM_011522715.4 | c.590T>C | p.Val197Ala | missense_variant | 3/15 | ||
SLX4 | XR_007064923.1 | n.1239T>C | non_coding_transcript_exon_variant | 3/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLX4 | ENST00000294008.4 | c.590T>C | p.Val197Ala | missense_variant | 3/15 | 5 | NM_032444.4 | P1 | |
SLX4 | ENST00000466154.5 | n.885T>C | non_coding_transcript_exon_variant | 2/7 | 1 | ||||
SLX4 | ENST00000486524.1 | n.1218T>C | non_coding_transcript_exon_variant | 3/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00135 AC: 206AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00139 AC: 349AN: 251466Hom.: 0 AF XY: 0.00149 AC XY: 202AN XY: 135902
GnomAD4 exome AF: 0.00199 AC: 2916AN: 1461888Hom.: 4 Cov.: 33 AF XY: 0.00196 AC XY: 1424AN XY: 727244
GnomAD4 genome AF: 0.00135 AC: 205AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.00133 AC XY: 99AN XY: 74488
ClinVar
Submissions by phenotype
Fanconi anemia complementation group P Uncertain:1Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. - |
Likely benign, criteria provided, single submitter | clinical testing | Baylor Genetics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | St. Jude Molecular Pathology, St. Jude Children's Research Hospital | Mar 17, 2021 | - - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 21, 2021 | - - |
Likely benign, no assertion criteria provided | curation | Leiden Open Variation Database | Aug 31, 2012 | Curator: Arleen D. Auerbach. Submitter to LOVD: Janine Bakker. - |
Fanconi anemia Benign:2
Benign, criteria provided, single submitter | curation | Sema4, Sema4 | Nov 29, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | SLX4: BP4 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 26, 2021 | Identified in the heterozygous state in individuals with familial breast cancer or with bone marrow failure (Landwehr et al., 2011; Fernandez-Rodriguez et al., 2012; Bakker et al., 2013; Shah et al., 2013; Maxwell et al., 2016; Arias-Salgado et al., 2019); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27153395, 21805310, 23840564, 22401137, 22911665, 30995915) - |
SLX4-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 17, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at